BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25321183)

  • 1. Risk of breast cancer with CXCR4-using HIV defined by V3 loop sequencing.
    Goedert JJ; Swenson LC; Napolitano LA; Haddad M; Anastos K; Minkoff H; Young M; Levine A; Adeyemi O; Seaberg EC; Aouizerat B; Rabkin CS; Harrigan PR; Hessol NA
    J Acquir Immune Defic Syndr; 2015 Jan; 68(1):30-5. PubMed ID: 25321183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
    Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
    J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher prevalence of predicted X4-tropic strains in perinatally infected older children with HIV-1 subtype C in India.
    Neogi U; Sahoo PN; Arumugam K; Sonnerborg A; De Costa A; Shet A
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):347-53. PubMed ID: 22107818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV tropism and decreased risk of breast cancer.
    Hessol NA; Napolitano LA; Smith D; Lie Y; Levine A; Young M; Cohen M; Minkoff H; Anastos K; D'Souza G; Greenblatt RM; Goedert JJ
    PLoS One; 2010 Dec; 5(12):e14349. PubMed ID: 21179547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two genotypic algorithms to determine HIV-1 tropism.
    Soulié C; Derache A; Aimé C; Marcelin AG; Carcelain G; Simon A; Katlama C; Calvez V
    HIV Med; 2008 Jan; 9(1):1-5. PubMed ID: 18199166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.
    Ceresola ER; Nozza S; Sampaolo M; Pignataro AR; Saita D; Ferrarese R; Ripa M; Deng W; Mullins JI; Boeri E; Tambussi G; Toniolo A; Lazzarin A; Clementi M; Canducci F
    J Antimicrob Chemother; 2015 May; 70(5):1391-5. PubMed ID: 25608585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis.
    Matume ND; Tebit DM; Bessong PO
    AIDS Res Ther; 2020 Feb; 17(1):5. PubMed ID: 32033571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.
    Matume ND; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Bessong PO
    J Clin Virol; 2018 Jun; 103():81-87. PubMed ID: 29661652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
    Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.
    Del Prete GQ; Leslie GJ; Haggarty B; Jordan AP; Romano J; Hoxie JA
    J Virol; 2010 Sep; 84(17):8777-89. PubMed ID: 20573813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing.
    Svicher V; Cento V; Rozera G; Abbate I; Santoro MM; Armenia D; Fabeni L; Bruselles A; Latini A; Palamara G; Micheli V; Rizzardini G; Gori C; Forbici F; Ippolito G; Andreoni M; Antinori A; Ceccherini-Silberstein F; Capobianchi MR; Perno CF
    PLoS One; 2013; 8(1):e53603. PubMed ID: 23341955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.
    Santoro MM; Armenia D; Fabeni L; Santoro M; Gori C; Forbici F; Svicher V; Bertoli A; Dori L; Surdo M; Balestra E; Palamara G; Girardi E; Angarano G; Andreoni M; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF
    Clin Microbiol Infect; 2012 Aug; 18(8):E289-98. PubMed ID: 22681969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
    J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates.
    Phuphuakrat A; Phawattanakul S; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
    HIV Med; 2014 May; 15(5):269-75. PubMed ID: 24215399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.
    Sánchez V; Masiá M; Robledano C; Padilla S; Lumbreras B; Poveda E; De Mendoza C; Soriano V; Gutiérrez F
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):51-8. PubMed ID: 21068675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.
    Ransy DG; Motorina A; Merindol N; Akouamba BS; Samson J; Lie Y; Napolitano LA; Lapointe N; Boucher M; Soudeyns H
    AIDS Res Hum Retroviruses; 2014 Mar; 30(3):312-24. PubMed ID: 24090041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
    Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of coreceptor tropism in PBMC samples from HIV-1 recently infected blood donors by massively parallel sequencing: the REDS II study.
    Pessôa R; Sabino EC; Sanabani SS
    Virol J; 2015 May; 12():74. PubMed ID: 25966986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.